EMA Authorised: Procoralan (ivabradine hydrochloride) — Les Laboratoires Servier

View source ↗

Summary

The European Medicines Agency has granted marketing authorization for Procoralan (ivabradine hydrochloride) for angina pectoris and heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Heart Failure

Drugs mentioned

• Procoralan (Ivabradine)

Snippet

Status: Authorised. Therapeutic area: Angina Pectoris;Heart Failure. MAH: Les Laboratoires Servier. Decision date: 13/11/2025